These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4879540)

  • 21. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use.
    Schrag SJ; Hadler JL; Arnold KE; Martell-Cleary P; Reingold A; Schuchat A
    Pediatrics; 2006 Aug; 118(2):570-6. PubMed ID: 16882809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diarrheas caused by pathogenic Escherichia coli strains and their treatment].
    Ocklitz HW; Schmidt EF
    Pediatr Pol; 1966 Aug; 41(8):897-904. PubMed ID: 5341175
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the diagnosis of dyspepsia coli bacteria by the indirect fluorescent antibody technique (sandwich method)].
    Heinrich S; Burckhardt F
    Zentralbl Bakteriol Orig; 1971; 216(2):193-8. PubMed ID: 4928075
    [No Abstract]   [Full Text] [Related]  

  • 25. Contributors to antibiotic resistance. Antibiotics should not be used for non-ulcer dyspepsia.
    Guslandi M
    BMJ; 1999 Mar; 318(7184):670. PubMed ID: 10215369
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sepsis due to E. coli in newborns with galactose intolerance (author's transl)].
    Scheerschmidt G; Handrick W; Spencker FB; Rieske K
    Padiatr Padol; 1981; 16(1):69-72. PubMed ID: 7017551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial therapy in children].
    Schneeweiss B; Briedigkeit W
    Munch Med Wochenschr; 1968 Dec; 110(49):2849-60. PubMed ID: 4885419
    [No Abstract]   [Full Text] [Related]  

  • 28. Reevaluating antibiotic therapy for urinary tract infections in children.
    Yared A; Edwards KM
    Arch Pediatr Adolesc Med; 2005 Oct; 159(10):992-3. PubMed ID: 16203947
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical picture, course and treatment of intestinal coli infections].
    Koloshtivina OV; Patrusheva TA; Vinogradova VA
    Vopr Okhr Materin Det; 1971 May; 16(5):43-6. PubMed ID: 4946907
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogenic Escherichia coli in a nursery.
    Chun FY; Tan KL
    J Singapore Paediatr Soc; 1971 Apr; 13(1):50-3. PubMed ID: 4934761
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Blot S; Vandijck D; Vandewoude K; Depuydt P; Vogelaers D; Peleman R
    J Antimicrob Chemother; 2007 Dec; 60(6):1402. PubMed ID: 17913718
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.
    Butler CC; Hillier S; Roberts Z; Dunstan F; Howard A; Palmer S
    Br J Gen Pract; 2006 Sep; 56(530):686-92. PubMed ID: 16954001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition and management of neonatal sepsis.
    Forgey CJ; Adamkin DH
    J Ky Med Assoc; 1980 Dec; 78(12):726-9. PubMed ID: 7003038
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis of enteropathogenic serotypes of Escherichia coli using the immunofluorescence technic].
    Klanica J; Novák O
    Cesk Epidemiol Mikrobiol Imunol; 1973 Jul; 22(4):232-6. PubMed ID: 4269838
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany.
    Raum E; Lietzau S; von Baum H; Marre R; Brenner H
    Clin Microbiol Infect; 2008 Jan; 14(1):41-8. PubMed ID: 18005177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lactobacterium in the treatment of coli-enteritis in infants].
    Balogh L; Zalay L; Záborszky B
    Orv Hetil; 1965 Sep; 106(36):1702-3. PubMed ID: 5317903
    [No Abstract]   [Full Text] [Related]  

  • 40. Transferable antibiotic resistance in Escherichia coli.
    Datta N
    Proc R Soc Med; 1971 May; 64(5):533-4. PubMed ID: 4930727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.